Published in J Biol Chem on February 10, 2006
CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization. Cancer Res (2008) 1.64
Semaphorin 3A suppresses tumor growth and metastasis in mice melanoma model. PLoS One (2012) 1.05
Down-regulation of osteopontin attenuates breast tumour progression in vivo. J Cell Mol Med (2008) 0.99
Breast cancer patients' clinical outcome measures are associated with Src kinase family member expression. Br J Cancer (2010) 0.98
Matrix metalloproteinase-9 inhibition down-regulates radiation-induced nuclear factor-kappa B activity leading to apoptosis in breast tumors. Clin Cancer Res (2008) 0.95
Tanshinone IIA inhibits HIF-1α and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway. PLoS One (2015) 0.85
Involvement of Src in the Adaptation of Cancer Cells under Microenvironmental Stresses. J Signal Transduct (2012) 0.81
Bioengineering embryonic stem cell microenvironments for the study of breast cancer. Int J Mol Sci (2011) 0.81
Oxidative stress decreases phosphatidylinositol 4,5-bisphosphate levels by deactivating phosphatidylinositol- 4-phosphate 5-kinase beta in a Syk-dependent manner. J Biol Chem (2009) 0.80
Phosphorylation of FOXP3 by LCK downregulates MMP9 expression and represses cell invasion. PLoS One (2013) 0.80
Nuclear localization of lymphocyte-specific protein tyrosine kinase (Lck) and its role in regulating LIM domain only 2 (Lmo2) gene. Biochem Biophys Res Commun (2011) 0.79
Lymphocyte-specific protein tyrosine kinase (Lck) interacts with CR6-interacting factor 1 (CRIF1) in mitochondria to repress oxidative phosphorylation. BMC Cancer (2015) 0.77
Association between the expression of IL-10 and T cell activation proteins loss in early breast cancer patients. J Cancer Res Clin Oncol (2008) 0.76
Transcriptional Network Architecture of Breast Cancer Molecular Subtypes. Front Physiol (2016) 0.75
Diverse Mechanisms of Sp1-Dependent Transcriptional Regulation Potentially Involved in the Adaptive Response of Cancer Cells to Oxygen-Deficient Conditions. Cancers (Basel) (2015) 0.75
Targeting Tumor Adaption to Chronic Hypoxia: Implications for Drug Resistance, and How It Can Be Overcome. Int J Mol Sci (2017) 0.75
Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol (2006) 3.48
Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase. J Biol Chem (2003) 2.05
Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition (2006) 1.92
Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms. Cancer Res (2008) 1.78
A novel experimental strategy to assess the metabolic effects of selective activation of a G(q)-coupled receptor in hepatocytes in vivo. Endocrinology (2013) 1.62
Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation. J Biol Chem (2004) 1.56
Probiotics in diverticular disease of the colon: an open label study. J Gastrointestin Liver Dis (2010) 1.50
Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha /IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways. J Biol Chem (2002) 1.49
The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis. Curr Mol Med (2006) 1.42
Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells. J Biol Chem (2003) 1.34
Prostaglandin E2 regulates tumor angiogenesis in prostate cancer. Cancer Res (2008) 1.31
Probiotics, their health benefits and applications for developing healthier foods: a review. FEMS Microbiol Lett (2012) 1.24
Intravesical delivery of rapamycin suppresses tumorigenesis in a mouse model of progressive bladder cancer. Cancer Prev Res (Phila) (2009) 1.22
Cancer-preventing attributes of probiotics: an update. Int J Food Sci Nutr (2010) 1.20
Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases. Exp Diabetes Res (2012) 1.17
Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells. J Biol Chem (2004) 1.13
Osteopontin: a potentially important therapeutic target in cancer. Expert Opin Ther Targets (2011) 1.11
Matrix metalloproteinase-2: mechanism and regulation of NF-kappaB-mediated activation and its role in cell motility and ECM-invasion. Glycoconj J (2004) 1.09
Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression. IUBMB Life (2005) 1.09
Osteopontin selectively regulates p70S6K/mTOR phosphorylation leading to NF-kappaB dependent AP-1-mediated ICAM-1 expression in breast cancer cells. Mol Cancer (2010) 1.08
Oral administration of dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats. J Dairy Res (2008) 1.06
Semaphorin 3A suppresses tumor growth and metastasis in mice melanoma model. PLoS One (2012) 1.05
Novel designer receptors to probe GPCR signaling and physiology. Trends Pharmacol Sci (2013) 1.03
Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells. Carcinogenesis (2009) 1.02
Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells. Mol Cancer (2010) 1.01
Osteopontin: an emerging therapeutic target for anticancer therapy. Expert Opin Ther Targets (2007) 0.99
Hyaluronan-binding protein 1 (HABP1/p32/gC1qR) induces melanoma cell migration and tumor growth by NF-kappa B dependent MMP-2 activation through integrin α(v)β(3) interaction. Cell Signal (2011) 0.99
Osteopontin as a therapeutic target for cancer. Expert Opin Ther Targets (2014) 0.99
Down-regulation of osteopontin attenuates breast tumour progression in vivo. J Cell Mol Med (2008) 0.99
Osteopontin stimulates melanoma growth and lung metastasis through NIK/MEKK1-dependent MMP-9 activation pathways. Oncol Rep (2007) 0.97
Retracted JNK1 differentially regulates osteopontin-induced nuclear factor-inducing kinase/MEKK1-dependent activating protein-1-mediated promatrix metalloproteinase-9 activation. J Biol Chem (2005) 0.97
Pro-survival effects of 17β-estradiol on osteocytes are mediated by nitric oxide/cGMP via differential actions of cGMP-dependent protein kinases I and II. J Biol Chem (2011) 0.95
Biological and medicinal properties of grapes and their bioactive constituents: an update. J Med Food (2009) 0.95
Nuclear factor inducing kinase: a key regulator in osteopontin- induced MAPK/IkappaB kinase dependent NF-kappaB-mediated promatrix metalloproteinase-9 activation. Glycoconj J (2006) 0.94
Rho isoform-specific interaction with IQGAP1 promotes breast cancer cell proliferation and migration. J Biol Chem (2012) 0.94
Biological synthesis of silver nanoparticles using the fungus Humicola sp. and evaluation of their cytoxicity using normal and cancer cell lines. Spectrochim Acta A Mol Biomol Spectrosc (2013) 0.94
Tyrosine kinase p56lck regulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through tyrosine phosphorylation of IkappaBalpha following hypoxia/reoxygenation. J Biol Chem (2003) 0.93
Molecular approaches for identification and characterization of lactic acid bacteria. J Dig Dis (2008) 0.93
The crucial role of cyclooxygenase-2 in osteopontin-induced protein kinase C alpha/c-Src/IkappaB kinase alpha/beta-dependent prostate tumor progression and angiogenesis. Cancer Res (2006) 0.93
p38 kinase is crucial for osteopontin-induced furin expression that supports cervical cancer progression. Cancer Res (2010) 0.93
Needle-based fluorescence endomicroscopy via structured illumination with a plastic, achromatic objective. J Biomed Opt (2013) 0.93
Bioactive peptides derived from milk proteins and their health beneficial potentials: an update. Food Funct (2010) 0.92
Curcumin suppresses breast tumor angiogenesis by abrogating osteopontin-induced VEGF expression. Mol Med Rep (2011) 0.92
Guanosine 3',5'-cyclic monophosphate (cGMP)/cGMP-dependent protein kinase induce interleukin-6 transcription in osteoblasts. Mol Endocrinol (2007) 0.90
Targeted cancer therapies: the future of cancer treatment. Acta Biomed (2012) 0.90
Exotic Fruits as Therapeutic Complements for Diabetes, Obesity and Metabolic Syndrome. Food Res Int (2011) 0.90
Alcohol, signaling, and ECM turnover. Alcohol Clin Exp Res (2009) 0.89
cGMP-dependent protein kinase Iβ regulates breast cancer cell migration and invasion via interaction with the actin/myosin-associated protein caldesmon. J Cell Sci (2013) 0.88
Complementary and comparative study on hypoglycemic and antihyperglycemic activity of various extracts of Eugenia jambolana seed, Momordica charantia fruits, Gymnema sylvestre, and Trigonella foenum graecum seeds in rats. Appl Biochem Biotechnol (2009) 0.88
Internet resources for diabetes. Indian J Med Sci (2005) 0.88
Medicinal and biological potential of pumpkin: an updated review. Nutr Res Rev (2010) 0.84
Preventive effect of diabegon, a polyherbal preparation, during progression of diabetes induced by high-fructose feeding in rats. J Pharmacol Sci (2007) 0.82
Biotechnological advancement in isolation of anti-neoplastic compounds from natural origin: a novel source of L-asparaginase. Acta Biomed (2010) 0.81
Effect of skim milk and dahi (yogurt) on blood glucose, insulin, and lipid profile in rats fed with high fructose diet. J Med Food (2006) 0.80
Functional foods in genomic medicine: a review of fermented papaya preparation research progress. Acta Biomed (2012) 0.80
Association of osteopontin and cyclooxygenase-2 expression with breast cancer subtypes and their use as potential biomarkers. Oncol Lett (2013) 0.80
Functional characterization of stromal osteopontin in melanoma progression and metastasis. PLoS One (2013) 0.79
Effect of Dahi containing Lactococcus lactis on the progression of diabetes induced by a high-fructose diet in rats. Biosci Biotechnol Biochem (2006) 0.79
Regulating redox balance gene expression in healthy individuals by nutraceuticals: a pilot study. Rejuvenation Res (2010) 0.79
Diosgenin Functionalized Iron Oxide Nanoparticles as Novel Nanomaterial Against Breast Cancer. J Nanosci Nanotechnol (2015) 0.79
One-pot fluorescent labeling protocol for complex hydroxylated bioactive natural products. J Org Chem (2013) 0.79
Quercetin and sulforaphane in combination suppress the progression of melanoma through the down-regulation of matrix metalloproteinase-9. Exp Ther Med (2010) 0.79
Cardioprotective effect of a biofermented nutraceutical on endothelial function in healthy middle-aged subjects. Rejuvenation Res (2012) 0.78
Tyrosine kinase, p56lck-induced cell motility, and urokinase-type plasminogen activator secretion involve activation of epidermal growth factor receptor/extracellular signal regulated kinase pathways. J Biol Chem (2003) 0.78
Critical metabolic roles of β-cell M3 muscarinic acetylcholine receptors. Life Sci (2012) 0.78
Protective effect of a phytocompound on oxidative stress and DNA fragmentation against paracetamol-induced liver damage. Ann Hepatol (2009) 0.78
Formation of oligosaccharides in skim milk fermented with mixed dahi cultures, Lactococcus lactis ssp diacetylactis and probiotic strains of lactobacilli. J Dairy Res (2007) 0.78
Minireview: Novel aspects of M3 muscarinic receptor signaling in pancreatic β-cells. Mol Endocrinol (2013) 0.78
A sturgeon-derived bioactive compound beneficially modulates nuclear receptors controlling metabolic functions in patients with metabolic syndrome. Acta Biomed (2013) 0.77
Modified dipeptide-based nanoparticles: vehicles for targeted tumor drug delivery. Nanomedicine (Lond) (2013) 0.77
The effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei on gastropathic consequences in diabetic rats. J Med Food (2008) 0.77
Evaluation of micronuclei induction capacity and mutagenicity of organochlorine and organophosphate pesticides. Drug Metab Lett (2012) 0.77
Beneficial modulation from a high-purity caviar-derived homogenate on chronological skin aging. Rejuvenation Res (2012) 0.76
Biomarine extracts significantly protect from ultraviolet A-induced skin photoaging: an ex vivo study. Rejuvenation Res (2012) 0.76
The potential of class 3 semaphorins as both targets and therapeutics in cancer. Expert Opin Ther Targets (2014) 0.76
Herbo-probiotic therapy in cardioprotection: a new way of nature to nurture. Nutrition (2013) 0.75
Corrigendum: Gs-coupled GPCR signalling in AgRP neurons triggers sustained increase in food intake. Nat Commun (2016) 0.75
Immune system and gut flora interactions are important episodes in metabolic diseases. J Gastrointestin Liver Dis (2012) 0.75
Anti-diabetic compounds and their patent information: an update. Recent Pat Inflamm Allergy Drug Discov (2013) 0.75
Improving sperm quality and spermatogenesis through a bioactive marine compound: an experimental study. Acta Biomed (2012) 0.75
Isolation, structure, and functional elucidation of a modified pentapeptide, cysteine protease inhibitor (CPI-2081) from Streptomyces species 2081 that exhibit inhibitory effect on cancer cell migration. J Med Chem (2010) 0.75
Status of research on matrix metalloproteinases (MMPs) in India. Expert Opin Ther Targets (2011) 0.75
A phytochemical approach to experimental metabolic syndrome-associated renal damage and oxidative stress. Rejuvenation Res (2012) 0.75